SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-003185
Filing Date
2022-03-18
Accepted
2022-03-18 16:05:27
Documents
1
Period of Report
2022-03-18

Document Format Files

Seq Description Document Type Size
1 form4-03182022_040310.html 4  
1 form4-03182022_040310.xml 4 3715
  Complete submission text file 0001415889-22-003185.txt   5209
Mailing Address ONE MAIN STREET, 10TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MAIN STREET, 10TH FLOOR CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Issuer) CIK: 0001701541 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 79 TW ALEXANDER DRIVE 4501 RESEARCH COMMONS, SUITE 100 RESEARCH TRIANGLE PARK NC 27709
Business Address
Velleca Mark A. (Reporting) CIK: 0001706847 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39200 | Film No.: 22752513